SARCLISA ESCENA vs TECVAYLI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. SARCLISA ESCENA and TECVAYLI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SARCLISA ESCENA	TECVAYLI
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ISATUXIMAB-IRFC	TECLISTAMAB-CQYV
Manufacturer	Sanofi-Aventis U.S. LLC	Janssen Biotech
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	Boxed warning
Treats	Multiple Myeloma	Multiple Myeloma

sarclisa escena tecvayli

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ISATUXIMAB-IRFC

TECLISTAMAB-CQYV

Manufacturer

Sanofi-Aventis U.S. LLC

Janssen Biotech

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Boxed warning

Treats

Multiple Myeloma

Frequently asked questions

What is the difference between Sarclisa Escena and Tecvayli?

Sarclisa Escena contains Isatuximab-Irfc, while Tecvayli contains Teclistamab-Cqyv — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.